321. Impact of the Swedish Care Coordination Act on Heart Failure Readmissions and Length of Stay.
作者: Robert S Kristiansson.;Douglas Spangler.;Wilhelm Linder.;Ulrika Winblad.
来源: Circ Heart Fail. 2025年18卷12期e012567页
Patients with heart failure tend to experience higher rates of hospital readmissions compared with other ambulatory care-sensitive conditions. In Sweden, the nationwide Care Coordination Act (CCA) was introduced in January 2018 with the goal of improving care coordination, resulting in a reduction of readmissions and length of stay. There is insufficient knowledge regarding the effect of this reform on patients with heart failure.
322. Combined Adaptive Immune Mechanisms Mediate Cardiac Injury After COVID-19 Vaccination.
作者: Silvia Fanti.;Carlene Dyer.;Inga Jóna Ingimarsdóttir.;Daniel Harding.;Guosu Wang.;Antonio D'Amati.;Eriomina Shahaj.;Adalbjorg Ýr Sigurbergsdóttir.;Helga Thórsdóttir.;Oddný Brattberg Gunnarsdóttir.;Stavroula Kanoni.;Paul Wright.;John Martin.;Jamie Chorlton.;Zoe Hollowood.;Siggeir Fannar Brynjólfsson.;Bjorn Rúnar Lúdvíksson.;Egle Solito.;Serena Bert.;Jack M Keane.;Saidi A Mohiddin.;M Paula Longhi.;Federica M Marelli-Berg.
来源: Circulation. 2025年152卷21期1485-1500页
The COVID-19 pandemic, caused by SARS-CoV-2, has led to the first approval of mRNA vaccines in humans. By producing the full-length SARS-CoV-2 Spike protein, they induce protective antiviral immunity. Acute myopericarditis (AMP) development after vaccination has repeatedly been reported; however, the pathogenesis of this complication remains elusive.
323. Nuclear eNOS Interacts With and S-Nitrosates ADAR1 to Modulate Type I Interferon Signaling and Endothelial Function.
作者: Xiaozhu Zhou.;Carsten Kuenne.;Stefan Günther.;Ilka Wittig.;Beyza Güven.;Doha Boutguetait.;Fredy Delgado Lagos.;Nadja Sachs.;Lars Maegdefessel.;Oliver J Müller.;Christian Münch.;Stefan Offermanns.;Ingrid Fleming.;Mauro Siragusa.
来源: Circulation. 2025年152卷25期1781-1799页
Nitric oxide (NO), generated by the endothelial NO synthase (eNOS), regulates vascular tone and endothelial homeostasis to counteract vascular inflammation. Most eNOS is localized at the cell membrane or in the Golgi apparatus, but the enzyme is also present in the endothelial cell nucleus. Here, we assessed the relevance of nuclear eNOS and NO signaling for endothelial cell function.
324. IRF5 siRNA Nanoimmunotherapy: Restoring Macrophage Efferocytosis in Atherosclerosis.
作者: Zhongshan He.;Yaoyao Luo.;Zhonghui Duan.;Bin Su.;Wanqin Zeng.;Yu Guo.;Yongjiang Li.;Xi He.;Haixing Shi.;Zhuoming Zhou.;Chunling Jiang.;Duotian Qin.;Ji Zhang.;Yan Kang.;Wei Chen.;Xiangrong Song.
来源: Circulation. 2025年152卷22期1564-1581页
Impaired efferocytosis of macrophages within advanced atherosclerotic plaques leads to plaque deposition and rupture, ultimately resulting in atherothrombotic events. Effective restoration of efferocytic capacity in lesional macrophages remains a challenge in atherosclerosis treatment.
325. CKAP4 Promotes Atrial Fibrosis and Enhances Atrial Fibrillation Vulnerability via WNT/β-Catenin Activation.
作者: Yuntao Feng.;Zhisong Chen.;Yanhua Gao.;Xuebo Liu.;Hongwei Tan.
来源: Circ Arrhythm Electrophysiol. 2025年18卷11期e014217页
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, characterized by atrial fibrosis, a crucial substrate facilitating its initiation and persistence. CKAP4 (cytoskeleton-associated protein 4) has been associated with fibroblast activation; however, its involvement in atrial remodeling and AF susceptibility remains unclear.
326. MEPPC Syndrome: A Systematic Review and State-of-the-Art Paper.
作者: Paolo Basile.;Maria Cristina Carella.;Stefania Zaccaro.;Marco Maria Dicorato.;Luca Sgarra.;Yamna Khan.;Gianluca Pontone.;Giovanni Luzzi.;Vincenzo Ezio Santobuono.;Cinzia Forleo.;Marco Matteo Ciccone.;Andrea Igoren Guaricci.
来源: Circ Arrhythm Electrophysiol. 2025年18卷11期e014113页
Multifocal ectopic Purkinje-related premature contractions syndrome presents as a rare cardiac disorder characterized by frequent multifocal ectopic ventricular beats with narrow QRS complexes, originating from various ectopic foci along the fascicular-Purkinje system. It is characterized by mutations in the SCN5A gene, inducing a gain-of-function in the human cardiac voltage-gated Na+ channel (Nav1.5), which causes an alteration in the action potentials of the cardiomyocytes. The syndrome was initially delineated in 2012 by Laurent et al in 3 Dutch families, subsequently garnering recognition through several reported cases worldwide. Clinically, it often manifests with a familial predisposition to other arrhythmogenic cardiac diseases, alongside symptoms such as palpitations and syncope. A key diagnostic hallmark is the high daily burden of multifocal premature ventricular contractions observed on 24-hour dynamic ECG, with evidence of repetitive ventricular arrhythmias. This can potentially induce a reversible form of left ventricular dilation with systolic dysfunction, known as premature ventricular contraction-induced cardiomyopathy. Diagnosis may be challenging, requiring exclusion of the most frequent causes of ventricular arrhythmias first. The disappearance of arrhythmias during a stress test and the inefficacy of catheter ablation procedures may serve as additional elements to bolster the suspicion of multifocal ectopic Purkinje-related premature contractions syndrome. Genetic testing and electrophysiological studies are pivotal in confirming the diagnosis. Therapeutic management of this syndrome primarily involves medical therapy with class I antiarrhythmic drugs, such as flecainide and quinidine, which may reduce ventricular arrhythmias and associated symptoms. In this systematic review, our aim was to provide an exhaustive insight into the genetic basis, diagnosis, and treatment strategies for this intriguing yet relatively underexplored syndrome.
327. Geometric Features of Ventricular Tachycardia Corridors in Patients With Ischemic Cardiomyopathy.
作者: Lingyu Xu.;Stanislau Hrybouski.;Ting-Wei Ernie Liao.;Jessie N Dong.;Mirmilad Khoshknab.;David J Callans.;Francis E Marchlinski.;Walter R Witschey.;Benoit Desjardins.;Saman Nazarian.
来源: Circulation. 2025年152卷23期1608-1620页
A 3-dimensional hyperboloid model has been proposed to characterize ventricular tachycardia (VT) circuitry. We sought to characterize the geometric features of viable corridors, derived from late gadolinium enhanced cardiovascular magnetic resonance, that participate in VT circuitry in ischemic cardiomyopathy.
328. Impact of Balloon Postdilation on Long-Term Bioprosthesis Durability After TAVR.
作者: Antonin Trimaille.;Pedro Cepas-Guillén.;Juan Hernando Del Portillo.;Carlos Giuliani.;Jean-Michel Paradis.;Eric Dumont.;Anthony Poulin.;Dimitri Kalavrouziotis.;Frederic Beaupré.;Jean Porterie.;Siamak Mohammadi.;Josep Rodés-Cabau.
来源: Circ Cardiovasc Interv. 2025年18卷12期e015577页
While balloon postdilation (BPD) during transcatheter aortic valve replacement may enhance hemodynamic performance by optimizing valve expansion, it was also linked with leaflet mechanical stress, potentially reducing valve durability. The aim of this study was to investigate the impact of BPD on long-term bioprosthetic valve durability.
329. Relation of Residual Mitral Regurgitation and Gradient Following Mitral Valve Transcatheter Edge-to-Edge Repair.
作者: Donika Mustafa.;Jennifer von Stein.;Lukas Stolz.;Jean Marc Haurand.;Matthias Gröger.;Felix Rudolph.;Jannik Jobst.;Christoph Alexander Mues.;Amir Abbas Mahabadi.;Isabel A Hoerbrand.;Carl Schulz.;Atsushi Sugiura.;Philipp Lurz.;Tobias Kister.;Paula Sagmeister.;Charlotte Wolff.;Muhammed Gerçek.;Patrick Horn.;Mirjam Kessler.;Guido Ascione.;Tienush Rassaf.;Marcel Weber.;Niklas Schofer.;Mathias H Konstandin.;Florian Schindhelm.;Helge Möllmann.;Bernhard Unsöld.;Henning Guthoff.;Stephan Baldus.;Wolfgang Rottbauer.;Volker Rudolph.;Juan F Granada.;Jörg Hausleiter.;Roman Pfister.;Victor Mauri.;Philipp von Stein.; .
来源: Circ Cardiovasc Interv. 2025年18卷11期e015845页
Residual mitral regurgitation (rMR) ≤1+ has been associated with improved 1-year outcomes after mitral valve transcatheter edge-to-edge repair, regardless of the mean mitral pressure gradient (MPG). Prior evidence is limited to 30-day echocardiographic follow-up and patients treated with the MitraClip (Abbott Structural Heart). Whether rMR and MPG assessed at discharge are associated with outcomes after PASCAL mitral valve transcatheter edge-to-edge repair (Edwards Lifesciences) remains unknown.
330. Role of Circadian Health in Cardiometabolic Health and Disease Risk: A Scientific Statement From the American Heart Association.
作者: Kristen L Knutson.;Debra D Dixon.;Michael A Grandner.;Chandra L Jackson.;Christopher E Kline.;Lisa Maher.;Nour Makarem.;Tami A Martino.;Marie-Pierre St-Onge.;Dayna A Johnson.; .
来源: Circulation. 2025年152卷21期e408-e419页
Cardiovascular and metabolic health are influenced by the circadian system, which regulates 24-hour rhythms across numerous physiologic processes. Disruptions to circadian rhythmicity can adversely affect cardiometabolic function and health. Given the importance of circadian health to overall human health, this scientific statement provides an overview of the circadian system and key behavioral factors that can synchronize or desynchronize these rhythms, including light exposure, food intake, physical exercise, and sleep timing. We also summarize the literature on associations between circadian health and cardiometabolic health indicators, such as excessive weight, type 2 diabetes (T2D), hypertension, and cardiovascular disease. We discuss strategies to improve circadian health and reduce circadian disruptions, focusing on interventions that target the key synchronizers of circadian rhythms and involve appropriate timing of exposure to these synchronizers. These include morning bright light exposure and avoidance of light at night, as well as appropriately timed sleep, meals, and exercise. Clinicians, researchers, policymakers, and the public should recognize the role of circadian rhythms in maintaining and promoting cardiometabolic health and focus on identifying modifiable behaviors that can improve them.
331. Comparison of Limus and Paclitaxel Drug-Coated Balloons, Second-Generation or Newer Drug-Eluting Stents, and Balloon Angioplasty: A Network Meta-Analysis of Randomized Controlled Trials.
作者: Yuko Kiyohara.;Tadao Aikawa.;Tetsuya Saito.;Abel Casso Dominguez.;Jose Wiley.;Dhaval Kolte.;Eric A Secemsky.;Robert W Yeh.;Roger J Laham.;Azeem Latib.;Deepak L Bhatt.;Toshiki Kuno.
来源: Circ Cardiovasc Interv. 2026年19卷1期e016005页
It remains unclear whether drug-coated balloons (DCBs) and drug-eluting stents are comparable in the treatment of coronary artery disease (CAD) and whether limus versus paclitaxel DCBs yield similar clinical outcomes. We aimed to assess the clinical efficacy of limus and paclitaxel DCBs in patients with CAD through a network meta-analysis.
332. The Role of the Collateral Circulation in Stable Angina: An Invasive Placebo-Controlled Study.
作者: Christopher A Rajkumar.;Michael J Foley.;Fiyyaz Ahmed-Jushuf.;Shayna Chotai.;Florentina A Simader.;Muhammad Mohsin.;Ahmed Salih.;Sashiananthan Ganesananthan.;Nina Bual.;Ricardo Petraco.;Sukhjinder S Nijjer.;Sayan Sen.;Joban Sehmi.;Neil Ruparelia.;Jason N Dungu.;Alamgir Kabir.;Kare Tang.;Reto Gamma.;John R Davies.;Tushar Kotecha.;Graham D Cole.;James P Howard.;Thomas R Keeble.;Gerald J Clesham.;Peter D O'Kane.;Frank E Harrell.;Darrel P Francis.;Matthew J Shun-Shin.;Rasha K Al-Lamee.
来源: Circulation. 2025年152卷22期1541-1551页
Little correlation exists between the burden of ischemia and severity of angina in patients with stable coronary artery disease. This placebo-controlled, n-of-1 study investigated the relationship between ischemia, the collateral circulation, and symptoms in stable coronary artery disease. Additionally, it explored the association between progressive collateral recruitment and ischemic preconditioning.
333. Prognostic Utility of Quantitative Perfusion PET in Patients With Prior CABG: Incremental Value of Myocardial Flow Reserve and Coronary Vascular Resistance.
作者: Yoshito Kadoya.;Edgar Da Silva.;Lulwa A AlTakroni.;Nuha Hejji.;Kevin E Boczar.;Benjamin J W Chow.;Robert A deKemp.;Terrence D Ruddy.;Rob S Beanlands.;Gary R Small.
来源: Circ Cardiovasc Imaging. 2025年18卷12期e018204页
The prognostic utility of quantitative positron emission tomography (PET) with myocardial blood flow (MBF) measurements in patients with prior coronary artery bypass grafting remains unestablished. We evaluated PET-derived myocardial flow reserve (MFR) and coronary vascular resistance (CVR) for risk stratification in patients who have undergone coronary artery pass grafting.
334. Transcatheter Valve Replacement in Adults With Congenital Heart Disease-The Mayo Clinic Experience.
作者: Alexander C Egbe.;Allison K Cabalka.;Nathaniel W Taggart.;Donald J Hagler.;Mackram F Eleid.;Charanjit S Rihal.;Jason H Anderson.
来源: Circ Cardiovasc Interv. 2025年18卷12期e015667页
The current study aims to describe outcomes after transcatheter valve replacement in adults with congenital heart disease.
335. Short-Term Anticoagulation Versus Dual Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure: The ANDES Randomized Clinical Trial.
作者: Josep Rodés-Cabau.;Luis Nombela-Franco.;Ignacio Cruz-Gonzalez.;Benjamin Hibbert.;Xavier Freixa.;Jean-Bernard Masson.;Réda Ibrahim.;Rodrigo Estevez-Loureiro.;Xavier Millan.;Malek Kass.;Jean-Michel Paradis.;Jean Champagne.;Pablo Salinas.;Ana Laffond.;Omar Abdel-Razek.;Marino Labinaz.;Pedro Cepas-Guillen.;Dabit Arzamendi.;Pablo Vidal-Cales.;Marco Pavesi.;Mélanie Côté.;Gilles O'Hara.;Erwan Salaun.
来源: Circulation. 2025年152卷25期1759-1768页
The optimal antithrombotic treatment after transcatheter left atrial appendage closure (LAAC) remains to be determined. The objective of this trial was to compare anticoagulation and antiplatelet therapy for preventing device-related thrombosis (DRT) after LAAC.
336. Impact of Pullback Pressure Gradient on Clinical Outcomes after Percutaneous Coronary Interventions.
作者: Kazumasa Ikeda.;Takuya Mizukami.;Koshiro Sakai.;Frederic Bouisset.;Jeroen Sonck.;Adriaan Wilgenhof.;Hitoshi Matsuo.;Toshiro Shinke.;Hirohiko Ando.;Masahiro Hada.;Brian Ko.;Simone Biscaglia.;Fernando Rivero.;Thomas Engstrøm.;Antonio Maria Leone.;Lokien X van Nunen.;William F Fearon.;Evald Høj Christiansen.;Stephane Fournier.;Liyew Desta.;Andy Yong.;Julien Adjedj.;Javier Escaned.;Masafumi Nakayama.;Ashkan Eftekhari.;Danielle Keulards.;Frederik M Zimmermann.;Tatyana Storozhenko.;Bruno R da Costa.;Gianluca Campo.;Colin Berry.;Damien Collison.;Thomas W Johnson.;Daniel Munhoz.;Tetsuya Amano.;Divaka Perera.;Allen Jeremias.;Ziad A Ali.;Takashi Kubo.;Kazuhiro Satomi.;Nobuhiro Tanaka.;Bernard De Bruyne.;Nils P Johnson.;Carlos Collet.
来源: Circ Cardiovasc Interv. 2025年18卷12期e016022页
Impaired flow following percutaneous coronary intervention (PCI) is a known predictor of adverse outcomes. The pullback pressure gradient (PPG) is a novel physiological metric that differentiates focal from diffuse disease and enables prediction of post-PCI fractional flow reserve (FFR). This post hoc analysis of the PPG Global (NCT04789317) study aimed to evaluate the prognostic performance of a PPG model for predicting post-PCI FFR and to determine whether the predicted physiological outcome is associated with adverse events following PCI.
337. Five-Year Clinical Outcomes and Durability of a Self-Expanding Transcatheter Heart Valve With Intra-Annular Leaflets.
作者: Rishi Puri.;Holger Thiele.;Stephan Fichtlscherer.;Dirk Westermann.;Raj Makkar.;Ron Waksman.;Samer Hakmi.;Lars Sondergaard.;Mark Groh.;Joseph K Montarello.;Joerg Kempfert.;Gerald Yong.;Francesco Bedogni.;Francesco Maisano.;Stephen G Worthley.;Josep Rodes-Cabau.;Gregory P Fontana.;Helge Möllmann.
来源: Circ Cardiovasc Interv. 2025年18卷12期e015430页
There is a paucity of data regarding the longer-term durability of transcatheter heart valves. This analysis aimed to describe the 5-year clinical outcomes and valve durability for patients treated with the Portico transcatheter heart valves across 3 studies harmonized in their prospective enrollment, inclusion/exclusion criteria, centralized independent core laboratory echocardiographic analysis, and independent clinical events committee adjudication.
338. Insights Into Early Adoption and Physician Learning Curve of Pulsed Field Ablation in the United States.
作者: Amin Al-Ahmad.;Daniela Hincapie-Tabares.;Paul C Zei.;Andrea Natale.;David Kessler.;Joe Gallinghouse.;Weeranun Bode.;Jose Osorio.;Jonathan W Dukes.;Robert Eckart.;Anish Amin.;Yoel Vivas.;Luis Mora.;Amit Thosani.;Joshua Silverstein.;Anil Rajendra.;Gustavo Morales.;Michael Manogue.;Joseph Donnelly.;Frank Cuoco.;Darren Sidney.;Robert Brewer.;Jason Meyers.;Mark D Metzl.;Guru Mohanty.;Michael Rehorn.;Paari Dominic.;John D Day.;Nischala Nannapaneni.;John Costello.; .
来源: Circ Arrhythm Electrophysiol. 2025年18卷11期e013982页
Pulsed field ablation (PFA) has been available in Europe since 2021. In the United States, PFA became commercially available in 2024, and practice patterns are expected to differ from those in Europe. The objective of this study was to describe acute procedural efficiency and safety outcomes, clinical workflow patterns, and the physician learning curve associated with PFA for paroxysmal and nonparoxysmal atrial fibrillation in the first US real-world registry.
339. Insurer Coverage of Invasive Coronary Angiography and Percutaneous Coronary Intervention for Stable Coronary Artery Disease in the United States Compared With Guidelines and Landmark Trials.
作者: Allison Kratka.;Christopher Gordon.;Vinay Guduguntla.;Rita F Redberg.;Sanket S Dhruva.
来源: Circ Cardiovasc Qual Outcomes. 2025年18卷11期e011497页
Invasive coronary angiography (ICA) and percutaneous coronary intervention (PCI) are common procedures for the diagnosis and treatment of coronary artery disease (CAD). These procedures are typically performed within the parameters of insurance coverage, but little is known about how insurance policies align with guidelines and landmark randomized clinical trials.
340. Part 12: Resuscitation Education Science: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
作者: Aaron J Donoghue.;Marc Auerbach.;Arna Banerjee.;Audrey L Blewer.;Adam Cheng.;Kelly D Kadlec.;Yiqun Lin.;Emily Diederich.;Taylor Sawyer.;Devita T Stallings.;Lorrel E B Toft.;Deborah Torman.;Jaylen I Wright.;Stephen M Schexnayder.;Katie N Dainty.
来源: Circulation. 2025年152卷16_suppl_2期S719-S750页
Developed by the American Heart Association, these Guidelines represent the first comprehensive update of education recommendations since 2020. Incorporating the results of structured evidence reviews from the International Liaison Committee on Resuscitation, these are guidelines for the design and delivery of resuscitation training for health care professionals and lay rescuers. This update emphasizes the continuous evolution of evidence evaluation and the necessity of adapting educational strategies to local needs and diverse community demographics. Existing guidelines remain relevant unless specifically updated in this publication. Key topics that are new, are substantially revised, or have significant new literature include the use of cardiopulmonary resuscitation feedback devices in training, rapid-cycle deliberate practice, teamwork and leadership training, manikin fidelity, gamified learning, virtual and augmented reality, use of cognitive aids, stepwise training, blended learning, scripted debriefing, instructor training, alternative objects for lay rescuer chest compression training, and special considerations for training in the management of opioid overdose. How certain personal considerations may influence the overall impact of education are also reviewed, including disparities accordingly related to gender, race, socioeconomic status, and language; the impact of training for school children; and factors that act as barriers or facilitators to lay rescuer willingness to perform cardiopulmonary resuscitation. We conclude with a summary of current knowledge gaps in resuscitation education science and a discussion of future directions for optimizing the impact of resuscitation training programs.
|